urapidil has been researched along with Adenoma, Prostatic in 5 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Twenty-two men with benign prostatic hyperplasia who were treated with a nonselective alpha 1-blocker (urapidil) were included." | 3.72 | Change in parameters before and after alpha-1-blocker therapy for men with lower urinary tract symptoms using color doppler ultrasound urodynamics: possible application for prediction of clinical outcome. ( Kumon, H; Nishiguchi, J; Nose, H; Ozawa, H; Watanabe, Y; Yokoyama, T, 2004) |
| "The adrenergic alpha-1 and -2 adrenoceptors in six human hypertrophied prostatic adenomas were measured in the saturation experiment using 3H-prazosin and 3H-yohimbine." | 3.68 | [Comparison of selective alpha-1 blockades for alpha-receptors in human hypertrophied prostatic adenomas]. ( Kondo, S; Morita, T, 1992) |
| " In summary, a daily dosage of 60 mg urapidil proved to be the most beneficial in the treatment of patients with BPH." | 2.67 | Effect on urapidil on benign prostatic hypertrophy: a multicenter, double-blind study. ( Kageyama, S; Kawabe, K; Morita, T; Shimazaki, J; Tsuchida, S; Yasuda, K, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Araki, T | 1 |
| Monden, K | 1 |
| Araki, M | 1 |
| Watanabe, Y | 1 |
| Yokoyama, T | 1 |
| Ozawa, H | 1 |
| Nishiguchi, J | 1 |
| Nose, H | 1 |
| Kumon, H | 1 |
| Takehara, Y | 1 |
| Igawa, K | 1 |
| Satoh, T | 1 |
| Yokozeki, H | 1 |
| Kawabe, K | 1 |
| Tsuchida, S | 1 |
| Shimazaki, J | 1 |
| Morita, T | 2 |
| Yasuda, K | 1 |
| Kageyama, S | 1 |
| Kondo, S | 1 |
2 trials available for urapidil and Adenoma, Prostatic
| Article | Year |
|---|---|
Comparison of 7 α(1)-adrenoceptor antagonists in patients with lower urinary tract symptoms associated with benign prostatic hyperplasia:a short-term crossover study.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Aged, 80 and over; Cross-Over Studies; Doxazos | 2013 |
Effect on urapidil on benign prostatic hypertrophy: a multicenter, double-blind study.
Topics: Adrenergic alpha-Antagonists; Double-Blind Method; Humans; Male; Piperazines; Prospective Studies; P | 1993 |
3 other studies available for urapidil and Adenoma, Prostatic
| Article | Year |
|---|---|
Change in parameters before and after alpha-1-blocker therapy for men with lower urinary tract symptoms using color doppler ultrasound urodynamics: possible application for prediction of clinical outcome.
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Humans; Male; Middle Aged; Piperazines; Predi | 2004 |
Psoriasiform eruption induced by alpha1-adrenergic blocker, urapidil.
Topics: Adrenergic alpha-Antagonists; Aged; Drug Eruptions; Erythema; Humans; Male; Piperazines; Prostatic H | 2007 |
[Comparison of selective alpha-1 blockades for alpha-receptors in human hypertrophied prostatic adenomas].
Topics: Adenoma; Adrenergic alpha-Antagonists; Aged; Humans; Male; Piperazines; Prazosin; Prostatic Hyperpla | 1992 |